We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Native EHR Achieves EU Medical Device Certification

By HospiMedica International staff writers
Posted on 26 May 2026

InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation (MDR), Regulation (EU) 2017/745. More...

IntelliCare is positioned as the first fully unified, AI-native EHR to achieve MDR Class IIa certification in the EU.

Built on the interoperability foundation of InterSystems TrakCare, IntelliCare is designed as a next-generation EHR with native AI capabilities. Unlike systems that rely on third-party AI add-ons, IntelliCare embeds AI directly into the platform’s data layer, enabling intelligence to be integrated across clinical workflows.

Designed to move beyond fragmented extensions, IntelliCare aims to simplify organizational oversight for governance and provide clinicians with tools intended to reduce workload and burnout. The platform delivers instant patient summaries, AI‑driven clinical documentation, full chat experiences, and intelligent workflows that maintain a “human‑in‑the‑loop” safeguard. 

Ambient clinical orchestration automatically captures, structures, and saves clinical data in real time, and suggests clinical documentation and orders for clinician approval. The system also connects with existing health information technology infrastructures, leveraging InterSystems’ experience in integration and data management.

The MDR certification signifies that the AI‑native EHR meets stringent European Union safety and quality standards. InterSystems characterizes this milestone as having important implications for responsibly scaling AI in healthcare while building confidence among providers and regulators.

“Healthcare organizations are rightfully demanding that AI be more than just an experimental add-on. By securing the EU’s first MDR certification for an AI-native EHR, we are establishing a standard that AI should be at the core of all healthcare applications,” said Don Woodlock, President, InterSystems.

Related Links
InterSystems


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Monitor/Defibrillator
Zenix
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.